Approves Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome. DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder. We recognize the… Read More
Order your Copy Today! We are beyond excited to share the 2025 O.R.S.A. Calendar, where art, resilience, and community come together form coast to coast in the most beautiful way! Created by individuals with Rett syndrome and their amazing… Read More
Social Media Frame Maker
Leave a Comment
Last Updated: 10/29/2024 by Steve
DAYBUE – Breaking News
Leave a Comment
Last Updated: 10/17/2024 by Steve
Approves Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE (trofinetide) for the Treatment of Rett Syndrome. DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare neurodevelopmental disorder. We recognize the… Read More
2025 Calendars
Leave a Comment
Last Updated: 11/20/2024 by Steve
Order your Copy Today! We are beyond excited to share the 2025 O.R.S.A. Calendar, where art, resilience, and community come together form coast to coast in the most beautiful way! Created by individuals with Rett syndrome and their amazing… Read More